The functions of N6-methyladenosine modification in lncRNAs
- PMID: 33335959
- PMCID: PMC7729116
- DOI: 10.1016/j.gendis.2020.03.005
The functions of N6-methyladenosine modification in lncRNAs
Abstract
Increasing evidence indicates that mRNAs are often subject to posttranscriptional modifications. Among them, N6-methyladenosine (m6A), which has been shown to play key roles in RNA splicing, stability, nuclear export, and translation, is the most abundant modification of RNA. Extensive studies of m6A modification of mRNAs have been carried out, while little is known about m6A modification of long non-coding RNAs (lncRNAs). Recently, several studies reported m6A modification of lncRNAs. In this review, we focus on these m6A-modified lncRNAs and discuss possible functions of m6A modification.
Keywords: Erasers; LncRNA; N6-methyladenosine; Readers; Writers.
© 2020 Chongqing Medical University. Production and hosting by Elsevier B.V.
Figures
Similar articles
-
Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.Front Oncol. 2021 Apr 13;11:635329. doi: 10.3389/fonc.2021.635329. eCollection 2021. Front Oncol. 2021. PMID: 33928028 Free PMC article. Review.
-
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.Front Oncol. 2022 Jul 22;12:927640. doi: 10.3389/fonc.2022.927640. eCollection 2022. Front Oncol. 2022. PMID: 35936737 Free PMC article. Review.
-
The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.Front Oncol. 2023 Mar 9;13:1063636. doi: 10.3389/fonc.2023.1063636. eCollection 2023. Front Oncol. 2023. PMID: 36969033 Free PMC article. Review.
-
N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.Exp Neurol. 2021 Nov;345:113829. doi: 10.1016/j.expneurol.2021.113829. Epub 2021 Jul 31. Exp Neurol. 2021. PMID: 34339678 Review.
-
Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.Biomed Pharmacother. 2023 Mar;159:114260. doi: 10.1016/j.biopha.2023.114260. Epub 2023 Jan 17. Biomed Pharmacother. 2023. PMID: 36657303 Review.
Cited by
-
RNA epigenetic modifications as dynamic biomarkers in cancer: from mechanisms to clinical translation.Biomark Res. 2025 Jun 7;13(1):81. doi: 10.1186/s40364-025-00794-y. Biomark Res. 2025. PMID: 40483535 Free PMC article. Review.
-
Characterization of Long Non-coding RNAs Modified by m6A RNA Methylation in Skeletal Myogenesis.Front Cell Dev Biol. 2021 Oct 13;9:762669. doi: 10.3389/fcell.2021.762669. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34722547 Free PMC article.
-
RNA modifications in aging-associated cardiovascular diseases.Aging (Albany NY). 2022 Sep 29;14(19):8110-8136. doi: 10.18632/aging.204311. Epub 2022 Sep 29. Aging (Albany NY). 2022. PMID: 36178367 Free PMC article. Review.
-
m6A-Atlas: a comprehensive knowledgebase for unraveling the N6-methyladenosine (m6A) epitranscriptome.Nucleic Acids Res. 2021 Jan 8;49(D1):D134-D143. doi: 10.1093/nar/gkaa692. Nucleic Acids Res. 2021. PMID: 32821938 Free PMC article.
-
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma.J Clin Transl Hepatol. 2022 Apr 28;10(2):308-320. doi: 10.14218/JCTH.2021.00096. Epub 2021 Jul 13. J Clin Transl Hepatol. 2022. PMID: 35528973 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources